1. ホーム
  2. 一覧
論文 特許

論文 - 一覧

  • 951 Hits
  • 検索条件 : 絞込み (生物種 = ヒト・動物細胞 AND 著者の国 = United States of America)
生物種 リソース名 タイトル
ヒト・動物細胞 Aska-SS(RCB3576) Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells.
ヒト・動物細胞 293T(RCB2202) Secreted phospholipase PLA2G5 acts as a hemolytic factor in sepsis.
ヒト・動物細胞 JHOS-4(RCB1678) The KIF18A Inhibitor ATX020 Induces Mitotic Arrest and DNA Damage in Chromosomally Instable High-Grade Serous Ovarian Cancer Cells.
ヒト・動物細胞 HCE-T(RCB2280) Optineurin modulates mTORC2/AKT/STAT3 signaling to control MHC class II expression and adaptive immunity against HSV-1.
ヒト・動物細胞 JHUCS-3(RCB1721) PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy.
ヒト・動物細胞 JHOC-5(RCB1520) , JHOC-7(RCB1688) , JHOC-8(RCB1723) , JHOC-9(RCB2226) PRSS23 promotes ovarian cancer peritoneal dissemination independent of protease activity.
ヒト・動物細胞 HuH-6(RCB1367) Dinaciclib improves treatment response in chemoresistant hepatoblastoma.
ヒト・動物細胞 Ca9-22(RCB1976) , HSC-2(RCB1945) , PC-12(RCB0009) Cytostatic Benzylidene-isophthaloylhydazides With Diminished Neurotoxicity.
ヒト・動物細胞 OV2944-HM-1(RCB1483) High-Throughput Microfluidic-Mediated Assembly of Layer-by-Layer Nanoparticles.
ヒト・動物細胞 PK-8(RCB2700) KRASG12R-Mutant Pancreatic Cancer Features Limited ERK/MAPK Transcriptional Activity and a Distinctive Tumor Microenvironment.
ヒト・動物細胞 CT29(RCB4937) Efficient Fluorescent Labeling of Human Trophoblast Stem Cells via a CRISPR/Cas9-Mediated Knock-In Approach in a Safe Harbor Locus.
ヒト・動物細胞 MH7A(RCB1512) Myostatin Regulates Inflammatory Cytokine and Chemokine Expression, Rheumatoid Arthritis Synovial Fibroblast Invasion, and CD4+ Th Cell Transmigration
ヒト・動物細胞 KP4(RCB1005) Combination of the MTA-Cooperative PRMT5 Inhibitor BMS-986504 and KRAS Inhibitors Is an Effective Treatment Strategy for MTAP-Deleted KRAS-Mutant Pancreatic Cancer.
ヒト・動物細胞 PK-1(RCB1972) , KP-4(RCB1005) De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer.
ヒト・動物細胞 Ba/F3(RCB0805) Zidesamtinib Selective Targeting of Diverse ROS1 Drug-Resistant Mutations.
ヒト・動物細胞 Yamato-SS(RCB3577) Pharmacologic degradation of WDR5 suppresses oncogenic activities of SS18::SSX and provides a therapeutic of synovial sarcoma.
ヒト・動物細胞 NUGC-4(RCB1939) Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers.
ヒト・動物細胞 OS-RC-2(RCB0735) Targeting of HIF2-driven cachexia in kidney cancer.
ヒト・動物細胞 HS-SY-II (RCB2231) , Yamato-SS(RCB3577) Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9.
ヒト・動物細胞 MKN28(RCB1000) , MKN45(RCB1001) Enhancing the antitumor efficacy using a combination of FGFR4 Inhibitor (H3B-6527) and oxaliplatin in gastric cancer.